The 5,000 implants were among Tranquil’s entire portfolio, including its ALIF, TLIF and DLIF devices, according to an Oct. 11 news release from the company.
“Through compliant mechanism engineering, we are able to appropriately and precisely match the stiffness of Tranquil to cancellous bone,” David Hawkes, president of Nexus Spine, said in the release. “This creates a safe zone of mechanical loading that promotes bone formation and stability through more rapid implant integration with the vertebral endplate.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.